Bimekizumab versus Ustekinumab Efficacy Across Subgroups of Patients with Moderate to Severe Plaque Psoriasis: Results from the Multicenter, Randomized, Double-Blinded Phase 3 BE VIVID Trial. J of Skin [Internet]. 2021 Jan. 1 [cited 2025 Apr. 19];5(1):s16. Available from: https://skin.dermsquared.com/skin/article/view/1169